Pharm
Hourly Subcutaneous Insulin
search
Hourly Subcutaneous Insulin
, Hourly Subcutaneous Insulin Aspart, Hourly Subcutaneous Insulin Lispro
See Also
Diabetic Ketoacidosis Management in Adults
Diabetic Ketoacidosis Management in Children
Insulin Infusion
Diabetic Ketoacidosis
Insulin
Bolus Insulin
Analog Basal Insulin
Glucose Metabolism
Type II Diabetes Medications
Type 1 Diabetes Mellitus
Indications
See
Diabetic Ketoacidosis Management in Adults
See
Diabetic Ketoacidosis Management in Children
Alternative to
Insulin Infusion
(
Insulin Drip
) in
Diabetic Ketoacidosis
Protocol
Adults
See
Diabetic Ketoacidosis Management in Adults
Gene
ral
Use subcutaneous
Rapid-Acting Insulin
(
Lispro
,
Aspart
)
Coadminister fluids as per
Diabetic Ketoacidosis
Discontinue hourly dosing when
Glucose
150-200
Monitor serum electolytes,
Serum Ketone
s, and
Venous Blood Gas
every 4 hours
Hourly SQ
Insulin
Protocol
Initial SQ bolus dose: 0.3 units/kg (other protocols start with 0.1 unit/kg)
Next: 0.1 units/kg/hour SQ until
Hyperglycemia
corrects (
Blood Glucose
<250 mg/dl)
Next: 0.05 units/kg/hour SQ until DKA resolves
Every 2 hour SQ
Insulin
Protocol
Initial SQ bolus dose: 0.3 units/kg
Next: 0.2 units/kg every 2 hours SQ until
Hyperglycemia
corrects (
Blood Glucose
<250 mg/dl)
Next: 0.1 units/kg every 2 hours SQ until DKA resolves
Protocol
Children
See
Diabetic Ketoacidosis Management in Children
Precautions
SQ
Insulin
for
DKA Management
is less established in children
Gene
ral
Use subcutaneous
Rapid-Acting Insulin
(
Lispro
,
Aspart
)
Coadminister fluids as per
Diabetic Ketoacidosis
Monitor serum electolytes,
Serum Ketone
s, and
Venous Blood Gas
every 4 hours
Every 2 hour SQ
Insulin
Protocol
Give 0.1 to 0.15 units/kg every 1-2 hours
Decrease dosing as
Hyperglycemia
corrects (
Blood Glucose
<250 mg/dl)
Precautions
Correct
Hypokalemia
prior to
Insulin Dosing
Fluid administration is central to DKA treatment
Monitoring
Blood Glucose
every 30 minutes to 1 hour
Advantage over Insulin Infusion
May be monitored on regular medical ward (non-ICU)
Reduced cost by 39% compared with infusion
Safety and efficacy
As effective and safe as
Insulin Infusion
References
Umpierrez (2004) Am J Med 117:291-6 [PubMed]
Karoli (2011) Indian J Pharmacol 43(4): 398-401 [PubMed]
Type your search phrase here